| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| sodelglitazar | peroxisome proliferator-activated receptor alpha | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperlipidemia[MeSHID:D006949] |
0.32 | discontinued in phase 2 | agonist |
| sodelglitazar | peroxisome proliferator-activated receptor delta | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperlipidemia[MeSHID:D006949] |
0.16 | discontinued in phase 2 | agonist |
| sodelglitazar | peroxisome proliferator-activated receptor gamma | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperlipidemia[MeSHID:D006949] |
0.15 | discontinued in phase 2 | agonist |
| click here to return to the previous page | ||||||||